x
Turning science into breakthroughs
Ancora Innovation empowers Vanderbilt scientists with the capital and infrastructure to execute novel and potentially transformative research projects.
On April 6, 2018, Vanderbilt University and Deerfield Management announced the launch of Ancora Innovation, a collaboration focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development.
Deerfield will fund Ancora Innovation with up to $65 million to pursue novel therapeutics and will provide additional capital to fund successful start-up companies that spin out of Ancora.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
Vanderbilt University researchers are at the forefront of discovery, innovation, scholarship, and creative expression. Our mission is to promote Vanderbilt’s distinctive research culture, which aspires to improve the human condition.
Project Submissions
To learn more about project sourcing and evaluation, please reach out to Ancora Innovation Alliance Manager Margaret Read at margaret.a.read@vanderbilt.edu.
Updates from Cure.
Cure. is a Deerfield affiliate and premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop groundbreaking products and services from concept to commercialization.
Content is generated and provided by third parties, including Cure, an affiliate of Ancora and Deerfield, and has not been reviewed or approved by Ancora or Deerfield.